The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.

BACKGROUND:Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), wh...

Full description

Bibliographic Details
Main Authors: Ricardo Aguas, José M L Lourenço, M Gabriela M Gomes, Lisa J White
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-08-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2722080?pdf=render
_version_ 1818497580564217856
author Ricardo Aguas
José M L Lourenço
M Gabriela M Gomes
Lisa J White
author_facet Ricardo Aguas
José M L Lourenço
M Gabriela M Gomes
Lisa J White
author_sort Ricardo Aguas
collection DOAJ
description BACKGROUND:Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), while allowing for immunity to build up. However, concerns as to whether immunity develops efficiently in treated individuals, and whether there is a rebound effect after treatment is halted, have made it imperative to define the effects that IPTi and IPTc exert on the clinical malaria scenario. METHODS AND FINDINGS:Here, we simulate several schemes of intervention under different transmission settings, while varying immunity build up assumptions. Our model predicts that infection risk and effectiveness of acquisition of clinical immunity under prophylactic effect are associated to intervention impact during treatment and follow-up periods. These effects vary across regions of different endemicity and are highly correlated with the interplay between the timing of interventions in age and the age dependent risk of acquiring an infection. However, even when significant rebound effects are predicted to occur, the overall intervention impact is positive. CONCLUSIONS:IPTi is predicted to have minimal impact on the acquisition of clinical immunity, since it does not interfere with the occurrence of mild infections, thus failing to reduce the underlying force of infection. On the contrary, IPTc has a significant potential to reduce transmission, specifically in areas where it is already low to moderate.
first_indexed 2024-12-10T18:47:15Z
format Article
id doaj.art-13ff5bf499964663b18333328841f5f2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T18:47:15Z
publishDate 2009-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-13ff5bf499964663b18333328841f5f22022-12-22T01:37:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-08-0148e662710.1371/journal.pone.0006627The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.Ricardo AguasJosé M L LourençoM Gabriela M GomesLisa J WhiteBACKGROUND:Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), while allowing for immunity to build up. However, concerns as to whether immunity develops efficiently in treated individuals, and whether there is a rebound effect after treatment is halted, have made it imperative to define the effects that IPTi and IPTc exert on the clinical malaria scenario. METHODS AND FINDINGS:Here, we simulate several schemes of intervention under different transmission settings, while varying immunity build up assumptions. Our model predicts that infection risk and effectiveness of acquisition of clinical immunity under prophylactic effect are associated to intervention impact during treatment and follow-up periods. These effects vary across regions of different endemicity and are highly correlated with the interplay between the timing of interventions in age and the age dependent risk of acquiring an infection. However, even when significant rebound effects are predicted to occur, the overall intervention impact is positive. CONCLUSIONS:IPTi is predicted to have minimal impact on the acquisition of clinical immunity, since it does not interfere with the occurrence of mild infections, thus failing to reduce the underlying force of infection. On the contrary, IPTc has a significant potential to reduce transmission, specifically in areas where it is already low to moderate.http://europepmc.org/articles/PMC2722080?pdf=render
spellingShingle Ricardo Aguas
José M L Lourenço
M Gabriela M Gomes
Lisa J White
The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
PLoS ONE
title The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
title_full The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
title_fullStr The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
title_full_unstemmed The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
title_short The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.
title_sort impact of ipti and iptc interventions on malaria clinical burden in silico perspectives
url http://europepmc.org/articles/PMC2722080?pdf=render
work_keys_str_mv AT ricardoaguas theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT josemllourenco theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT mgabrielamgomes theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT lisajwhite theimpactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT ricardoaguas impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT josemllourenco impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT mgabrielamgomes impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives
AT lisajwhite impactofiptiandiptcinterventionsonmalariaclinicalburdeninsilicoperspectives